For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Globally, "women were 50% more likely to receive effective treatment despite men having more than twice the substance use ...
By offering no-cost treatment, the organization hopes to bring attention to the financial barriers that prevent people from ...
Mental health and substance abuse continues to be a serious concern in Florida. Data published last month in Forbes puts the ...
The Involuntary Treatment Act provides for court-ordered mental health or substance abuse disorder treatment. It can be enacted when a person is deemed a danger to themselves, others or others ...
It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...
Some 70 community mental health and substance abuse treatment providers gathered in Tallahassee to mark Behavioral Health Day ...
He often counsels people dealing with drug abuse issues.“It’s in the moment that’s really important for them to get what they ...
The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results